Safety and Pharmacokinetics Study of Oral Lithium in Patients With Chronic Spinal Cord Injury
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The current study is a phase I open-label clinical trial to examine plasma levels after oral
lithium treatments in 20 subjects with chronic spinal cord injury. The subjects will receive
standard doses of oral lithium used in treatment of manic depression. The goal of the trial
is to show feasibility and safety of maintaining plasma levels of 0.6 mmol/L to 1.2 mmol/L
for six weeks in subjects with chronic spinal cord injury.